Call for Abstracts for SNMMI 2018 Annual Meeting

Physicians, scientists, technologists, lab professionals, and educators/course directors working in the field of nuclear medicine and molecular imaging are invited to submit original abstracts. DEADLINE: January 9, 2018, for all except technologist students (Their deadline is February 9).

SNMMI Submits Comments to NRC on Radioactive Materials

SNMMI has submitted comments to the Nuclear Regulatory Commission (NRC) on its open petition for rulemaking, asking that its regulations be revised to include radionuclides and their corresponding activities to the list of "Quantities of Licensed Material Requiring Labeling." 

Novel Nuclear Medicine Test Can Identify Kidney Transplant Infection

German scientists have developed a novel nuclear medicine test that can determine whether a kidney transplant patient has developed infection in the transplanted tissue. The study, which utilizes PET/MRI, is presented in the November issue of The Journal of Nuclear Medicine.  

SNMMI Commends FDA for Release of Microdose Guidance

SNMMI believes this guidance will help illuminate a clear pathway to full drug development (marketing authorization) for microdose radiopharmaceutical diagnostic drugs. It has the potential to provide valuable information and guidance for technical and physical requirements that are applicable to microdose radiopharmaceutical diagnostic drugs.

SNMMI NEWS

  • November 16, 2017 — Call for Abstracts for SNMMI 2018 Annual Meeting
    The SNMMI Scientific Program Committee invites physicians, scientists, technologists, lab professionals, and educators/course directors working in the field of nuclear medicine and molecular imaging to submit original abstracts. DEADLINE: January 9, 2018, for all except technologist students (Their deadline is February 9). (SNMMI News)
  • November 14, 2017 — SNMMI Submits Comments to NRC on Naturally Occurring and Accelerator-Produced Radioactive Materials
    SNMMI has submitted comments to the NRC on its open petition for rulemaking, asking that its regulations be revised to include radionuclides and their corresponding activities to the list of "Quantities of Licensed Material Requiring Labeling." (Government Relations News)
  • November 13, 2017 — SNMMI Commends FDA for Release of Microdose Guidance
    SNMMI recently submitted comments to FDA on its draft guidance for microdose radiopharmaceutical diagnostic drugs. (Government Relations News)
  • November 8, 2017 — Novel Nuclear Medicine Test Can Identify Kidney Transplant Infection
    German scientists have developed a novel nuclear medicine test that can determine whether a kidney transplant patient has developed infection in the transplanted tissue. The study, which utilizes positron emission tomography/magnetic resonance imaging (PET/MRI), is presented in the November issue of The Journal of Nuclear Medicine. (Press Releases)
  • November 6, 2017 — FDG PET Shows Tumor DNA Levels in Blood Are Linked to NSCLC Aggressiveness
    Insights derived from FDG PET could improve treatment selection for patients with advanced non-small cell lung cancer. The study is presented in the featured clinical investigation article of the November issue of The Journal of Nuclear Medicine. (Press Releases)
  • November 3, 2017 — SNMMI’s 2016 Annual Report Receives MARCOM Platinum Award
    "SNMMI: The Integral Thread – 2016 Annual Report" has received a MARCOM Platinum Award for excellence in communications and marketing. This recognition highlights the report’s successful representation of the innovative and collaborative nuclear medicine and molecular imaging research and clinical application process for which SNMMI is truly an integral thread. (SNMMI News)
  • November 3, 2017 — CMS Issues Final Rules for 2018
    Final rules on Medicare for 2018 include the Physician Fee Schedule (PFS), Hospital Outpatient Prospective Payment System (OPPS) and Quality Payment Program (QPP). This is a preliminary summary of how the rules affect nuclear medicine and molecular imaging. There are some tweaks, but no major surprises or changes. For example, the mandate that referring physician consult Appropriate Use Criteria (AUCs) is pushed back from 2018 to 2020. (Government Relations News)
  • November 2, 2017 — New System for Treating Colorectal Cancer Can Lead to Complete Cure
    Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technology in Boston have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer. In this study with a mouse model, researchers achieved a 100-percent cure rate—without any treatment-related toxic effects. The study is reported in the November featured article in The Journal of Nuclear Medicine. (Press Releases)

CONTINUING EDUCATION

Latest Journal CE and Journal SAMS:

Just Released! Radiation Safety+ Review and Essentials

The new Radiation Safety+ Review and Essentials program provides a comprehensive overview of all aspects of radiation safety for nuclear medicine technologists preparing to take the NMTCB’s Radiation Safety Certification Examination.  This 5 module/7.75 credit course also includes a 150 question mock exam lets you assess what you've learned! Learn More »

CT+ Review and Essentials

CT+ Review and Essentials provides you with the comprehensive didactic education you need to succeed, whether you're looking to build your general CT knowledge, or preparing to sit for the ARRT (CT) and/or NMTCB (CT) exam(s). This 18 module/17 credit course also includes a post-course mock exam lets you assess what you've learned! Learn More »

2017 Virtual Poster Hall and Virtual Meeting   

Virtual Poster Hall 

View Scientific Abstract Oral and Poster Presentations from SNMMI's 2017 Annual Meeting. Learn More »

Virtual Meeting

Access synchronized slides, audio and embedded video from 100 of the most popular sessions from SNMMI’s 2017 Annual Meeting. Learn More »

Nuclear Medicine Online Review Course

SNMMI's online nuclear medicine review course covers adult and pediatric medicine, PET/CT and nuclear cardiology plus imaging protocols, interpretation and limitation. Learn More »

Case Reviews

SNMMI/ACNM MRI Case Reviews: Abdominal
SNMMI and ACNM have partnered to bring you the first-ever set of online MRI teaching modules as an introduction to interpreting MRI. Learn More »

Mid-Winter Meeting CT Case Reviews

This offering provides a comprehensive CT Case Review for nuclear medicine professionals. Review and interpret up to 100 CT studies. Learn More »

Annual Meeting CT/MRI Case Reviews
Recorded at the Annual Meeting, this online offering provides the opportunity to review and interpret 52 CT studies and 48 MRI case studies. Learn More »

Member Benefit! Complimentary Journal SAMs/Journal CE

Free Journal SAM/CE access is available exclusively for SNMMI Members. Take advantage of this great benefit and meet your certification requirements. Learn more »

PET Online Review Workshop for Technologists

Fee recently reduced! The PET Online Review Workshop is designed to prepare technologists for the NMTCB's PET Exam. Learn More »

PUBLICATIONS

UPCOMING EVENTS

2018 SNMMI Mid-Winter and ACNM Annual Meeting

January 25-27, 2018 | Orlando, FL
Register | Learn More
Early-bird registration deadline: December 7, 2017

AACR-SNMMI Joint Conference on State-of-the-Art Molecular Imaging in Cancer Biology and Therapy

February 14-17, 2018 | San Diego, CA
Register | Learn more
Advance registration deadline: December 18, 2017

SNMMI 2018 Annual Meeting

June 23-26, 2018 | Philadelphia, PA
Learn more | Submit an Abstract - now open!

POP QUIZ

According to the SNMMI/ASNC/SCCT guidelines, how long should patients abstain from caffeine prior to a myocardial perfusion imaging (MPI) procedure?

  A. At least 24 hours
  B. At least 18 hours
  C. At least 12 hours
  D. At least 6 hours

  Sponsored by Astellas
alt Text
Advertisement

SPOTLIGHT

Join our Global Professional Community

Learn about exclusive SNMMI Member Benefits--valued at more than $1,000.


Join SNMMI today!

FDG: Forty Years of Changing Lives

For 40 years, FDG has been helping patients get better, faster. Today, FDG PET is widely used to safely and accurately diagnose, evaluate, and plan therapy of cancer and heart, lung and brain diseases for millions of patients.

Featured Jobs from SNMMI's Career Center 

 

Visit SNMMI's Career Center »

EDUCATION AND RESEARCH FOUNDATION

The Education and Research Foundation (ERF) LogoERF secures, invests and distributes funding to support rigorously vetted physicians, scientists and technologists in the pursuit of advanced academic studies or breakthrough discoveries in the field. Learn More »